APLS Apellis Pharmaceuticals, Inc.
Fundamentals / CIK 0001492422 / USDApellis Pharmaceuticals, Inc. reported $1.11B in revenue and net income of $133.3M for the trailing twelve months ended March 31, 2026 (up 60.9% year over year), with a 14.9% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open APLS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$1.11B +60.9% YoY
-
Operating Income TTM$165.2M 14.9% margin
-
Net Income TTM$133.3M 12.1% net margin
-
Diluted EPS TTM$1.01 Split-adjusted
-
Free Cash Flow TTM$45.01M 4.1% FCF margin
-
Cash & ST Investments Mar 31, 2026$405.2M Total debt: $19.77M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.00B | $781.4M | $396.6M | $75.42M | $66.56M | $250.6M | -- | -- | -- | -- |
| Research & Development | $295.9M | $327.6M | $354.4M | $387.2M | $345.9M | $299.9M | $221.0M | $105.3M | $40.30M | $22.98M |
| Selling, General & Admin | $550.3M | $501.1M | $500.8M | $277.2M | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | $948.4M | $946.3M | $913.7M | $670.0M | $602.8M | $464.4M | $288.0M | $127.9M | -- | -- |
| Operating Income | $55.43M | -$165.0M | -$517.1M | -$594.6M | -$536.3M | -$213.7M | -$288.0M | -$127.9M | -$50.77M | -$27.28M |
| EBITDA | $56.98M | -$163.2M | -$515.3M | -$593.1M | -$534.9M | -$213.1M | -$287.8M | -- | -- | -- |
| Interest Expense | $44.33M | $40.39M | $29.58M | $32.63M | $12.05M | $3.58M | -- | -- | -- | -- |
| Income Before Tax | $24.11M | -$196.7M | -$526.5M | -$651.5M | -$746.0M | -$343.0M | -$304.7M | -$127.5M | -$51.01M | -- |
| Income Tax Expense | $1.72M | $1.16M | $2.13M | $669K | $352K | $1.84M | -- | -- | -- | -- |
| Net Income | $22.39M | -$197.9M | -$528.6M | -$652.2M | -$746.4M | -$344.9M | -$304.7M | -$127.5M | -$51.01M | -$27.12M |
| Basic EPS | $0.18 | -$1.60 | -$4.45 | -$6.15 | -$8.84 | -$4.59 | -$4.90 | -$2.34 | -$3.68 | -$3.22 |
| Diluted EPS | $0.20 | -$1.60 | -$4.45 | -$6.15 | -$8.84 | -$4.59 | -$4.90 | -$2.34 | -$3.68 | -$3.22 |
| Basic Shares Outstanding | 126.1M | 123.9M | 118.7M | 106.1M | 84.4M | 75.2M | 62.2M | 54.4M | 13.9M | 8.4M |
| Diluted Shares Outstanding | 129.9M | 123.9M | 118.7M | 106.1M | 84.4M | 75.2M | 62.2M | 54.4M | 13.9M | 8.4M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $268.3M | $199.9M | $458.6M | $178.5M | $166.8M | $212.5M | $196.8M | $199.7M |
| Research & Development | $76.96M | $74.23M | $68.19M | $67.02M | $86.42M | $76.35M | $88.57M | $77.95M |
| Selling, General & Admin | $124.3M | $147.1M | $142.7M | $131.1M | $129.3M | $121.5M | $122.0M | $128.1M |
| Total Operating Expenses | $241.8M | $251.1M | $235.4M | $211.8M | $250.1M | $238.7M | $244.1M | $229.1M |
| Operating Income | $26.47M | -$51.14M | $223.2M | -$33.29M | -$83.33M | -$26.16M | -$47.28M | -$29.44M |
| EBITDA | $26.76M | -$50.81M | $223.5M | -$32.84M | -$82.88M | -$25.72M | -$46.82M | -$28.99M |
| Interest Expense | $10.32M | $10.85M | $11.28M | $11.15M | $11.05M | $11.53M | $12.53M | $9.36M |
| Income Before Tax | $19.15M | -$58.64M | $216.3M | -$41.69M | -$91.88M | -$36.07M | -$56.85M | -$37.54M |
| Income Tax Expense | $496K | $313K | $602K | $466K | $341K | $286K | $592K | $114K |
| Net Income | $18.66M | -$58.95M | $215.7M | -$42.15M | -$92.22M | -$36.35M | -$57.45M | -$37.66M |
| Basic EPS | $0.15 | -- | $1.71 | -$0.33 | -$0.74 | -- | -$0.46 | -$0.30 |
| Diluted EPS | $0.15 | -- | $1.67 | -$0.33 | -$0.74 | -- | -$0.46 | -$0.30 |
| Basic Shares Outstanding | 127.7M | -- | 126.4M | 126.0M | 125.5M | -- | 124.2M | 123.9M |
| Diluted Shares Outstanding | 131.4M | -- | 130.1M | 126.0M | 125.5M | -- | 124.2M | 123.9M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $466.2M | $411.3M | $351.2M | $551.8M | $640.2M | $565.8M | $352.0M | $176.3M | $175.6M | $24.86M |
| Short-Term Investments | -- | -- | -- | -- | $60.36M | $311.9M | -- | -- | -- | -- |
| Cash & Short-Term Investments | $466.2M | $411.3M | $351.2M | $551.8M | $700.5M | $877.6M | $352.0M | $176.3M | $175.6M | $24.86M |
| Accounts Receivable, Net | $366.2M | $264.9M | $206.4M | $7.73M | $10.10M | -- | -- | -- | -- | -- |
| Inventory | $142.6M | $81.40M | $146.4M | $85.71M | $16.29M | $0 | -- | -- | -- | -- |
| Other Current Assets | -- | $11.64M | $22.41M | $36.66M | $70.68M | $26.88M | $1.31M | $1.84M | $15K | $25K |
| Total Current Assets | $1.01B | $789.0M | $766.3M | $719.5M | $824.0M | $917.2M | $373.1M | $202.4M | $182.0M | $27.37M |
| Property, Plant & Equipment, Net | $1.71M | $2.95M | $4.34M | $6.15M | $6.18M | $6.80M | $1.66M | $978K | -- | -- |
| Other Non-Current Assets | $5.55M | $1.35M | $1.31M | $15.80M | $31.64M | $18.86M | $385K | $116K | $116K | $65K |
| Total Non-Current Assets | $60.42M | $96.10M | $22.40M | $40.69M | $57.72M | $43.38M | $16.15M | $1.09M | $116K | $65K |
| Total Assets | $1.08B | $885.1M | $788.7M | $760.2M | $881.8M | $960.6M | $389.2M | $203.5M | $182.1M | $27.43M |
| Accounts Payable | $56.80M | $38.57M | $37.52M | $37.34M | $16.91M | $8.48M | $8.36M | $10.25M | $3.66M | $2.55M |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | -- | $1.67M | -- | -- |
| Total Current Liabilities | $323.6M | $185.5M | $247.6M | $167.6M | $131.8M | $128.3M | $65.75M | $17.02M | $6.55M | $3.64M |
| Long-Term Debt | -- | -- | $93.03M | $92.74M | -- | -- | -- | -- | $27.00M | -- |
| Other Non-Current Liabilities | $7.90M | $7.97M | $2.31M | -- | -- | -- | -- | $159K | -- | -- |
| Total Non-Current Liabilities | $381.5M | $471.0M | $346.6M | $422.7M | $551.3M | $627.7M | $289.3M | $25.54M | $26.63M | $0 |
| Total Liabilities | $705.1M | $656.5M | $594.2M | $590.3M | $683.1M | $756.0M | $355.0M | $42.56M | $33.19M | $3.64M |
| Total Debt (incl. Leases) | $19.03M | $16.95M | $110.9M | $112.7M | $21.20M | $18.90M | $14.47M | $1.67M | $27.00M | -- |
| Common Stock | $12K | $12K | $12K | $11K | $10K | $8.0K | $6.0K | $5.6K | $5.0K | $843 |
| Retained Earnings | -$3.01B | -$3.04B | -$2.84B | -$2.31B | -$1.66B | -$926.3M | -$581.5M | -$276.8M | -$149.3M | -$98.26M |
| Accumulated Other Comp. Income | -$2.10M | -$3.31M | -$3.54M | -$875K | -$2.09M | -$117K | -$154K | -$123K | -- | -- |
| Total Stockholders' Equity | $370.1M | $228.5M | $194.5M | $169.9M | $198.7M | $204.6M | $34.23M | $161.0M | $148.9M | $23.79M |
| Total Equity | $370.1M | $228.5M | $194.5M | $169.9M | $198.7M | $204.6M | $34.23M | $161.0M | $148.9M | $23.79M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $405.2M | $466.2M | $479.2M | $370.0M | $358.4M | $411.3M | $396.9M | $360.1M |
| Cash & Short-Term Investments | $405.2M | $466.2M | $479.2M | $370.0M | $358.4M | $411.3M | $396.9M | $360.1M |
| Accounts Receivable, Net | $440.3M | $366.2M | $345.5M | $214.1M | $235.2M | $264.9M | $279.0M | $304.4M |
| Inventory | $131.4M | $142.6M | $122.8M | $121.0M | $82.47M | $81.40M | $121.1M | $152.8M |
| Other Current Assets | -- | -- | $10.16M | $19.84M | $13.07M | $11.64M | $11.78M | $12.37M |
| Total Current Assets | $1.03B | $1.01B | $990.7M | $755.6M | $727.7M | $789.0M | $833.9M | $860.0M |
| Property, Plant & Equipment, Net | $1.42M | $1.71M | $1.93M | $2.12M | $2.51M | $2.95M | $3.38M | $3.84M |
| Other Non-Current Assets | $5.66M | $5.55M | $5.49M | $898K | $1.15M | $1.35M | $1.45M | $1.33M |
| Total Non-Current Assets | $54.51M | $60.42M | $68.05M | $65.78M | $79.57M | $96.10M | $67.97M | $44.51M |
| Total Assets | $1.08B | $1.08B | $1.06B | $821.4M | $807.3M | $885.1M | $901.9M | $904.5M |
| Accounts Payable | $49.05M | $56.80M | $38.60M | $54.24M | $55.29M | $38.57M | $42.73M | $38.27M |
| Total Current Liabilities | $283.4M | $323.6M | $279.5M | $200.7M | $178.4M | $185.5M | $191.3M | $169.2M |
| Other Non-Current Liabilities | $9.11M | $7.90M | $3.26M | $2.08M | $2.08M | $7.97M | $9.83M | $2.69M |
| Total Non-Current Liabilities | $384.2M | $381.5M | $378.0M | $464.4M | $464.7M | $471.0M | $473.5M | $471.0M |
| Total Liabilities | $667.6M | $705.1M | $657.6M | $665.1M | $643.1M | $656.5M | $664.7M | $640.2M |
| Total Debt (incl. Leases) | $19.77M | $19.03M | $20.70M | $15.73M | $16.13M | $16.95M | $18.20M | $17.30M |
| Common Stock | $13K | $12K | $12K | $12K | $12K | $12K | $12K | $12K |
| Retained Earnings | -$2.99B | -$3.01B | -$2.95B | -$3.17B | -$3.13B | -$3.04B | -$3.00B | -$2.94B |
| Accumulated Other Comp. Income | -$2.41M | -$2.10M | -$2.40M | -$2.57M | -$3.05M | -$3.31M | -$3.14M | -$3.36M |
| Total Stockholders' Equity | $414.9M | $370.1M | $401.2M | $156.3M | $164.2M | $228.5M | $237.1M | $264.3M |
| Total Equity | $414.9M | $370.1M | $401.2M | $156.3M | $164.2M | $228.5M | $237.1M | $264.3M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $22.39M | -$197.9M | -$528.6M | -$652.2M | -$746.4M | -$344.9M | -$304.7M | -$127.5M | -$51.01M | -$27.12M |
| Depreciation & Amortization | $1.56M | $1.80M | $1.78M | $1.55M | $1.38M | $637K | $240K | -- | -- | -- |
| Stock-Based Compensation | $104.0M | $114.1M | $105.9M | $91.08M | $70.67M | $45.38M | $21.14M | $7.73M | $5.42M | $1.08M |
| Change in Receivables | -$101.3M | -$58.48M | -$198.7M | $2.38M | -$10.10M | -- | -- | -- | -- | -- |
| Change in Inventory | -$15.27M | -$10.76M | -$60.65M | -$69.40M | -$16.32M | -- | -- | -- | -- | -- |
| Change in Payables | $18.22M | $1.09M | $170K | $18.69M | $10.49M | -$54K | -$1.64M | -$978K | -$52K | $70K |
| Operating Cash Flow | $45.33M | -$87.87M | -$594.7M | -$513.7M | -$563.1M | -$160.5M | -$211.1M | -$131.2M | -$46.60M | -$26.00M |
| Capital Expenditure | -$313K | -$403K | -$773K | -$1.52M | -$1.10M | -$5.42M | -$1.69M | -- | -- | -- |
| Free Cash Flow | $45.01M | -$88.27M | -$595.5M | -$515.3M | -$564.2M | -$165.9M | -$212.8M | -- | -- | -- |
| Purchases of Investments | -- | -- | -- | -$331.9M | -$171.3M | -$879.1M | -- | -- | -- | -- |
| Investing Cash Flow | -$313K | -$403K | -$674K | $59.89M | $247.6M | -$317.0M | -$1.69M | -- | -- | -- |
| Common Stock Issued | -- | -- | -- | $380.1M | $380.4M | $381.4M | $109.6M | $131.2M | $150.1M | -- |
| Financing Cash Flow | $8.88M | $149.2M | $394.5M | $365.7M | $392.2M | $692.2M | $388.5M | $131.9M | $197.4M | $14.86M |
| Net Change in Cash | $55.15M | $60.31M | -$200.8M | -$88.68M | $74.71M | $215.1M | $175.7M | $624K | $150.8M | -$11.14M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $18.66M | -$58.95M | $215.7M | -$42.15M | -$92.22M | -$36.35M | -$57.45M | -$37.66M |
| Depreciation & Amortization | $291K | $327K | $339K | $446K | $446K | $447K | $457K | $449K |
| Stock-Based Compensation | $25.17M | $21.25M | $28.19M | $27.20M | $27.37M | $26.31M | $27.48M | $29.99M |
| Change in Receivables | -$74.07M | -$20.67M | -$131.4M | $21.12M | $29.68M | $14.09M | $25.42M | -$36.58M |
| Change in Inventory | $18.81M | -$8.66M | $5.40M | -$26.01M | $14.00M | $10.02M | $8.65M | -$14.51M |
| Change in Payables | -$7.74M | $18.20M | -$15.64M | -$1.04M | $16.71M | $1.49M | -$1.16M | $11.49M |
| Operating Cash Flow | -$60.97M | -$14.18M | $108.5M | $4.45M | -$53.41M | $19.36M | $34.10M | -$8.34M |
| Capital Expenditure | -- | -$108K | -$148K | -$49K | -$8.0K | -$20K | $0 | -$90K |
| Free Cash Flow | -- | -$14.28M | $108.3M | $4.40M | -$53.42M | $19.34M | $34.10M | -$8.43M |
| Investing Cash Flow | -- | -$108K | -$148K | -$49K | -$8.0K | -$20K | $0 | -$90K |
| Financing Cash Flow | $64K | $1.26M | $793K | $6.56M | $274K | -$4.00M | $2.54M | $42.49M |
| Net Change in Cash | -$61.03M | -$12.84M | $109.1M | $11.64M | -$52.78M | $14.38M | $36.81M | $34.40M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 5.5% | -21.1% | -130.4% | -788.4% | -805.7% | -85.3% | -- | -- | -- | -- |
| Net Profit Margin | 2.2% | -25.3% | -133.3% | -864.7% | -1121.3% | -137.6% | -- | -- | -- | -- |
| Return on Equity (ROE) | 6.0% | -86.6% | -271.8% | -383.9% | -375.7% | -168.6% | -890.2% | -79.2% | -34.2% | -114.0% |
| Return on Assets (ROA) | 2.1% | -22.4% | -67.0% | -85.8% | -84.6% | -35.9% | -78.3% | -62.6% | -28.0% | -98.9% |
| Current Ratio | 3.14x | 4.25x | 3.10x | 4.29x | 6.25x | 7.15x | 5.67x | 11.89x | 27.77x | 7.52x |
| Quick Ratio | 2.70x | 3.81x | 2.50x | 3.78x | 6.13x | 7.15x | 5.35x | 10.35x | 26.80x | 6.83x |
| Debt to Equity | 0.05x | 0.07x | 0.57x | 0.66x | 0.11x | 0.09x | 0.42x | 0.01x | 0.18x | -- |
| Revenue Growth (YoY) | +28.5% | +97.0% | +425.8% | +13.3% | -73.4% | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +138.6% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 14.9% | 5.5% | 7.9% | -25.2% | -24.0% | -21.1% | -31.2% | -49.8% |
| Net Profit Margin | 12.1% | 2.2% | 4.4% | -30.2% | -28.8% | -25.3% | -35.0% | -52.9% |
| Return on Equity (ROE) | 32.1% | 6.0% | 11.2% | -146.0% | -136.2% | -86.6% | -105.5% | -125.9% |
| Return on Assets (ROA) | 12.3% | 2.1% | 4.2% | -27.8% | -27.7% | -22.4% | -27.7% | -36.8% |
| Current Ratio | 3.63x | 3.14x | 3.54x | 3.77x | 4.08x | 4.25x | 4.36x | 5.08x |
| Quick Ratio | 3.16x | 2.70x | 3.10x | 3.16x | 3.62x | 3.81x | 3.73x | 4.18x |
| Debt to Equity | 0.05x | 0.05x | 0.05x | 0.10x | 0.10x | 0.07x | 0.08x | 0.07x |
| Revenue Growth (YoY) | +60.9% | -5.9% | +133.0% | -10.6% | -3.2% | +45.2% | +78.3% | +110.3% |
| Operating Cash Flow Growth (YoY) | -- | -173.2% | +218.1% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -173.9% | +217.7% | -- | -- | -- | -- | -- |